US Supreme Court split on Teva case


The US Supreme Court was split yesterday (October 15) after hearing arguments in a high-profile case that will determine whether generic drug companies are free to market a cheaper version of Teva’s blockbuster multiple sclerosis drug.

patent, generic, Teva, Mylan, Natco, Sandoz, Momenta, Copaxone